NewslettersCell Therapy NewsKyverna Therapeutics and ElevateBio to Advance Kyverna’s Ingenui-T Cell Therapy ManufacturingBy lbeveridge - October 4, 20230173Kyverna Therapeutics and ElevateBio, LLC announced a partnership to advance process development and manufacturing to produce industry-leading Ingenui-T-derived chimeric antigen receptor (CAR) T-cell therapies.[Kyverna Therapeutics]Press Release